Thymidylate synthase from untreated human colorectal cancer and colonic mucosa: Enzyme activity and inhibition by 5-fluoro-2′-deoxyuridine-5′-monophosphate

European Journal of Cancer and Clinical Oncology

Volumn 27, Issue 3, 1991, Pages 263-267

  Peters, Godefridus J ^a   van Groeningen, Cees J ^a   Laurensse, Emile J ^a,b   Pinedo, Herbert M ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Eurocetas ^*  (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE PHOSPHATE; THYMIDYLATE SYNTHASE;

ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BINDING SITES; COLON; COLONIC NEOPLASMS; DEOXYURACIL NUCLEOTIDES; FLUORODEOXYURIDYLATE; HUMAN; INTESTINAL MUCOSA; MIDDLE AGE; RECTAL NEOPLASMS; SUPPORT, NON-U.S. GOV'T; THYMIDYLATE SYNTHASE;

EID: 0025903919     PISSN: 02775379     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-5379(91)90512-C     Document Type: Article

References (37)

1. Inhibition of mammalian tumour thymidylate synthetase by 5-alkylated 2′-deoxyuridine 5′-monophosphate
2. Human leukemic cells resistant to 5-fluoro-2′ deoxyuridine contain a thymidylate synthase with lower affinity for nucleotides
3. Thymidylate synthetase — a target enzyme in cancer chemotherapy
4. 5-fluorouracil: biochemistry and pharmacology
5. Leucovorin/5-fluorouracil: response and toxicity in relation to quality of life
6. Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma
7. Selective expansion of 5,10-methylene-tetrahydrofolate pools and modulation of 5-fluorouracil antitumor activity by leucovorin in vivo
8. Development of leucovorin/5-fluorouracil combinations
9. Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer
10. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil
11. Evidence for the existence of covalent nucleotide-thymidylate synthase complexes, identification of site of attachment, and enhancement by folates
12. Genetic variation in thymidylate synthase structure is associated with 5-fluoropyrimidine resistance in human colonic tumor cells
13. Characterization of the pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in xenografts of human colon adenocarcinoma
14. Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil
15. Increased thymidylate synthetase in 5-fluorodeoxyuridine resistant cultured hepatoma cells
16. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells
17. Thymidylate synthase overproduction gene amplification in a colon tumor resistant to fluoropyrimidine chemotherapy
18. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2′-deoxyuridine in a human colon tumor cell line
19. In vitro and in vivo inhibition of thymidylate synthase of human colon cancer by 5-fluorouracil
20. Sensitivity of human, murine and rat cells to 5-fluorouracil and 5′-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes
21. Tissue homogenization using a microdismembrator for the measurement of enzyme activities
22. In vivo kinetics of thymidylate synthase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas
23. Separation and use of enterocytes
24. Stimulation by phytohemagglutinin of peripheral blood lymphocytes from horse, pig, sheep and man
25. 3H]deoxyuridine-5′-monophosphate in the thymidylate synthase assay
26. Differences in fluoropyrimidine metabolism between human colon tumors and colonic mucosa
27. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa
28. Chromosomal and enzymatic patterns provide evidence for two types of human colon cancers with abnormal nucleotide metabolism
29. Thymidylate synthetase activity and fluorouracil sensitivity of human colonic cancer and normal mucosal tissue preparations
30. Thymidylate synthases isolated from human colon tumours have varied affinity towards 5-fluoro-2′-deoxyuridylate
31. Increased thymidylate synthase (EC 2.1.1.45) activity in normal and neoplastic proliferation
32. Allelotype of colorectal carcinomas
33. Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity
34. Deoxyuridylate effects on thymidylate synthase-5-fluorodeoxyuridylate-folate ternary complex formation
35. The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthase covalent complex in human colon xenografts
36. Toxicity of fluoropyrimidines and leucovorin to rat small intestinal epithelial cells
37. Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma